Diagnosis & Disease Information

Researchers sought to evaluate first-line treatment of patients with advanced-stage MCL who were younger than 66 years of age.

Researchers sought to conduct a long-term follow-up study of brexucabtagene autoleucel in patients with MCL.

Researchers sought to determine whether rituximab maintenance therapy would have a clinical benefit in elderly patients with mantle cell lymphoma.

Researchers sought to determine whether ibrutinib would improve survival outcomes in patients with MCL who had CNS involvement at relapse.